| The urgent need to recover MHC class I in cancers for effective immunotherapy F Garrido, N Aptsiauri, EM Doorduijn, AMG Lora, T Van Hall Current opinion in immunology 39, 44-51, 2016 | 662 | 2016 |
| “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy F Garrido, T Cabrera, N Aptsiauri International journal of cancer 127 (2), 249-256, 2010 | 346 | 2010 |
| Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis RF Mullins, N Aptsiauri, GS Hageman Eye 15 (3), 390-395, 2001 | 298 | 2001 |
| The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy G Adamus, N Aptsiauri, J Guy, J Heckenlively, J Flannery, PA Hargrave Clinical immunology and immunopathology 78 (2), 120-129, 1996 | 195 | 1996 |
| Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma AB Del Campo, JA Kyte, J Carretero, S Zinchencko, R Méndez, ... International journal of cancer 134 (1), 102-113, 2014 | 193 | 2014 |
| MHC class I antigens and immune surveillance in transformed cells N Aptsiauri, T Cabrera, A Garcia‐Lora, MA Lopez‐Nevot, F Ruiz‐Cabello, ... International review of cytology 256, 139-189, 2007 | 177 | 2007 |
| Role of altered expression of HLA class I molecules in cancer progression N Aptsiauri, T Cabrera, R Mendez, A Garcia-Lor, F Ruiz-Cabello, ... Immune-Mediated Diseases: From Theory to Therapy, 123-131, 2007 | 175 | 2007 |
| Rejection versus escape: the tumor MHC dilemma F Garrido, F Ruiz-Cabello, N Aptsiauri Cancer immunology, immunotherapy 66, 259-271, 2017 | 170 | 2017 |
| Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa JR Heckenlively, BL Jordan, N Aptsiauri American journal of ophthalmology 127 (5), 565-573, 1999 | 170 | 1999 |
| Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases J Guy, N Aptsiauri Archives of Ophthalmology 117 (4), 471-477, 1999 | 162 | 1999 |
| Cancer immune escape: MHC expression in primary tumours versus metastases F Garrido, N Aptsiauri Immunology 158 (4), 255-266, 2019 | 151 | 2019 |
| Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration JR Heckenlively, AA Fawzi, J Oversier, BL Jordan, N Aptsiauri Archives of ophthalmology 118 (11), 1525-1533, 2000 | 125 | 2000 |
| Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines T Rodríguez, R Méndez, A Del Campo, P Jiménez, N Aptsiauri, F Garrido, ... BMC cancer 7, 1-11, 2007 | 123 | 2007 |
| Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors I Maleno, N Aptsiauri, T Cabrera, A Gallego, A Paschen, MA López-Nevot, ... Immunogenetics 63, 65-71, 2011 | 113 | 2011 |
| The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses N Aptsiauri, F Ruiz-Cabello, F Garrido Current opinion in immunology 51, 123-132, 2018 | 109 | 2018 |
| High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer JM Cozar, JM Romero, N Aptsiauri, F Vazquez, JR Vilchez, M Tallada, ... Human immunology 68 (8), 698-704, 2007 | 108 | 2007 |
| The escape of cancer from T cell-mediated immune surveillance: HLA class I loss and tumor tissue architecture F Garrido, F Perea, M Bernal, A Sánchez-Palencia, N Aptsiauri, ... Vaccines 5 (1), 7, 2017 | 100 | 2017 |
| HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape F Perea, A Sánchez-Palencia, M Gómez-Morales, M Bernal, Á Concha, ... Oncotarget 9 (3), 4120, 2018 | 85 | 2018 |
| Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations N Aptsiauri, R Carretero, A Garcia-Lora, LM Real, T Cabrera, F Garrido Cancer Immunology, Immunotherapy 57, 1727-1733, 2008 | 85 | 2008 |
| HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy P Anderson, N Aptsiauri, F Ruiz-Cabello, F Garrido Cellular & molecular immunology 18 (3), 556-565, 2021 | 80 | 2021 |
Federico GarridoCatedrático Universidad de Granada在 ugr.es 的电子邮件经过验证
